Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 2C19 Inducers [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
ENZALUTAMIDE 49,270 9,676 19.6% 9,282 576 76.0 yrs 0.6%
CARBAMAZEPINE 24,577 2,156 8.8% 9,608 1,705 50.1 yrs 61.8%
DABRAFENIB 19,305 4,165 21.6% 5,325 500 58.3 yrs 48.0%
PHENYTOIN 14,469 1,449 10.0% 5,241 1,087 46.5 yrs 50.7%
RITONAVIR 11,980 1,190 9.9% 2,925 350 43.8 yrs 43.8%
SPARSENTAN 3,280 18 0.5% 209 2 49.3 yrs 43.8%
LETERMOVIR 1,416 252 17.8% 398 50 46.6 yrs 42.7%
FOSPHENYTOIN 1,378 166 12.0% 646 261 37.5 yrs 52.4%
MITAPIVAT 627 4 0.6% 58 1 46.6 yrs 53.5%
NIROGACESTAT 497 7 1.4% 54 5 45.2 yrs 69.6%

Head-to-Head Comparisons

ENZALUTAMIDE vs CARBAMAZEPINE ENZALUTAMIDE vs DABRAFENIB ENZALUTAMIDE vs PHENYTOIN ENZALUTAMIDE vs RITONAVIR CARBAMAZEPINE vs DABRAFENIB CARBAMAZEPINE vs PHENYTOIN CARBAMAZEPINE vs RITONAVIR DABRAFENIB vs PHENYTOIN DABRAFENIB vs RITONAVIR PHENYTOIN vs RITONAVIR
← Back to Cytochrome P450 2C19 Inducers [MoA] Class side effects →